尼尔塞维玛布对RSV支气管炎在儿科门诊护理中的有效性:一个测试负的病例对照研究
Yannis Lassoued1,2, Corinne Levy3,4,5,6,7, Andreas Werner3,4,5
1Department of General Paediatrics, Paediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, 75019, Paris, France.
The Lancet regional health. Europe
|August 14, 2024
概括
在12个月以下的婴儿中,nirsevimab在门诊环境中有效地预防了呼吸道综合体病毒 (RSV) 支气管炎. 这项许可后的研究证实了nirsevimab在预防RSV感染方面的实际有效性.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 呼吸道同胞病毒 (RSV) 是儿童下呼吸道感染的主要原因之一.
- 对RSV的一种单克隆抗体Nirsevimab于2023年底推出.
- 它在现实世界的门诊环境中的有效性仍未得到评估.
研究的目的:
- 为了评估尼尔塞维玛布对RSV-支气管炎的许可后有效性.
- 为了评估nirsevimab在12个月以下的门诊患者的疗效.
主要方法:
- 使用国家门诊监测数据进行了一项测试阴性病例控制研究.
- 包括12个月以下患有支气管炎的婴儿和RSV快速抗原测试结果.
- 使用逻辑回归来确定有效性,调整为混因素.
主要成果:
- 分析了883名患有支气管炎的婴儿 (453例RSV阳性病例,430例RSV阴性对照).
- 对RSV-支气管炎的nirsevimab疗效为79.7% (95%CI为67.7-87.3).
- 敏感性分析证实了这些发现的可靠性.
结论:
- 在门诊护理中,nirsevimab在预防RSV-支气管炎方面表现出显著的有效性.
- 这项研究支持使用nirsevimab在幼儿中预防RSV.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


